(Q24247742)

2

0 references

Jane Marjoribanks

1

0 references

Ussanee S Sangkomkamhang

4

object named as

Ussanee S Sangkomkamhang

0 references

Roos S Derks

5

object named as

Roos S Derks

0 references

author name string

M. L. Proctor

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583938

26 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14583938

26 March 2024

publication date

20 October 2003

0 references

2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14583938

full work available at URL

26 March 2024

https://onlinelibrary.wiley.com/doi/full/10.1002/14651858.CD001751

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Cochrane Database of Systematic Reviews

26 March 2024

published in

0 references

cites work

Comparison of ketoprofen and naproxen in the treatment of dysmenorrhoea, with special regard to the time of onset of pain relief

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Dynamics and significance of placebo response in primary dysmenorrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Indomethacin in the treatment of primary dysmenorrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Flufenamic acid in treatment of primary spasmodic dysmenorrhoea. A double-blind crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

A crossover comparison of bromfenac sodium, naproxen sodium, and placebo for relief of pain from primary dysmenorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Ibuprofen and naproxen-sodium in the treatment of primary dysmenorrhea: a double-blind cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Comparison of the efficacy and safety of nonprescription doses of naproxen and naproxen sodium with ibuprofen, acetaminophen, and placebo in the treatment of primary dysmenorrhea: a pooled analysis of five studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

A double-blind, placebo-controlled study comparing three single-dose regimens of piroxicam with ibuprofen in patients with primary dysmenorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Alterations in intrauterine pressure, menstrual fluid prostaglandin F levels, and pain in dysmenorrheic women treated with nimesulide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Treatment of primary dysmenorrhea with diclofenac sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Piroxicam in primary dysmenorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Zomepirac sodium in the treatment of primary dysmenorrhea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

The effect of naproxen-sodium on the intrauterine pressure and menstrual pain of dysmenorrheic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Flurbiprofen in dysmenorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

The influence of anxiety and locus of control on adolescents' response to naproxen sodium for mild to moderate pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Ibuprofen is a useful treatment for primary dysmenorrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Differential response by adolescents to naproxen sodium therapy for spasmodic and congestive dysmenorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

The relief of primary dysmenorrhea by ketoprofen and indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Flurbiprofen in the treatment of primary dysmenorrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Treatment of Primary Dysmenorrhea with Prostaglandin Synthetase Inhibitors—a Promising Therapeutic Alternative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

The effect of naproxen-sodium on the prostaglandin concentrations of the menstrual blood and uterine “jet-washings” in dysmenorrehic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

The effect of ibuprofen on the intrauterine pressure and menstrual pain of dysmenorrheic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Effect of ibuprofen on menstrual blood prostaglandin levels in dysmenorrheic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Flurbiprofen for the treatment of primary dysmenorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Objective changes in intrauterine pressure during placebo treatment of dysmenorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Simultaneous objective and subjective evaluation of meclofenamate sodium in the treatment of primary dysmenorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

A comparison of tiaprofenic acid, mefenamic acid and placebo in the treatment of dysmenorrhoea in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Comparison between naproxen tablets and suppositories in primary dysmenorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

The effect of nimesulide and naproxen on the uterine and ovarian arterial blood flow velocity. A Doppler study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Can primary dysmenorrhea be alleviated by a vasopressin antagonist? Results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Prevalence and impact of dysmenorrhea on Hispanic female adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Non-steroidal anti-inflammatory drugs. Current status and rational therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

Ketoprofen, ibuprofen, and placebo in the treatment of primary dysmenorrhea: a double-blind crossover comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Treating dysmenorrhea with anti-inflammatory agents: a double-blind trial with naproxen sodium

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Treatment of Primary Dysmenorrhea with Mefenamic Acid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Comparison of the Efficacy and Tolerability of Dexketoprofen and Ketoprofen in the Treatment of Primary Dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Prostaglandins in primary dysmenorrhea. Comparison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Anaprox in dysmenorrhea: Reduction of pain and intrauterine pressure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Naproxen sodium in uterine pain following intrauterine contraceptive device insertion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

The objective evaluation of dysmenorrhea therapy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

The uterine contractility index: A research and diagnostic tool in dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Dysmenorrhea in women with intrauterine contraceptive device. Treatment with a prostaglandin synthetase inhibitor, naproxen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Tiaprofenic acid in the treatment of primary dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Prostaglandin biosynthesis inhibitors and endometriosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Severe, primary dysmenorrhea treated with naproxen. A prospective, double-blind, crossover investigation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Comparison between fluproquazone and indomethacin in treatment of primary dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Diflunisal compared with naproxen in the treatment of dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Ibuprofen and dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

The effect of aspirin on dysmenorrhea in adolescents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Naproxen in dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Primary dysmenorrhea in young Western Australian women: prevalence, impact, and knowledge of treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Analgesic efficacy of ibuprofen for treatment of primary dysmenorrhea.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Comparative Efficacy of Ibuprofen, Indomethacin, and Placebo in the Treatment of Primary Dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Menstrual blood loss in dysmenorrhoea: effects of proquazone and indomethacin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Effect of ibuprofen, naproxen sodium and paracetamol on intrauterine pressure and menstrual pain in dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Tolfenamic acid and mefenamic acid in the treatment of primary dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Effect of small doses of aspirin and acetaminophen on total menstrual loss and pain of cramps and headache

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Do aspirin and acetaminophen affect total menstrual loss?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

‘Buscopan’ in spasmodic dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Prostaglandins and Dysmenorrhea Historical survey

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

The Effect of Inhibitors of Prostaglandin Synthesis in Primary Dysmenorrhea Studied with Hysterometry

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Endogenous Prostaglandins in Dysmenorrhea and the Effect of Prostaglandin Synthetase Inhibitors (PGSI) on Uterine Contractility

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Prostaglandin Synthetase Inhibitors and Dysmenorrhea: A Survey and Personal Clinical Experience

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Effect of Acetylsalicylic Acid, Paracetamol and Placebo on Pain and Blood Loss in Dysmenorrheic Women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Naproxen and Indomethacin in the Treatment of Primary Dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Suppression of Menstrual Prostaglandins and Relief of Dysmenorrhea with Ibuprofen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Clinical Experience of Naproxen in the Treatment of Primary Dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Naproxen and Naproxen Sodium in Dysmenorrhea: Development from in vitro Inhibition of Prostaglandin Synthesis to Suppression of Uterine Contractions in Women and Demonstration of Clinical Efficacy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Piroxicam in the treatment of primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Current concepts in the etiology and treatment of primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

A comparative crossover study of piroxicam vs. mefenamic acid and diclofenac in France

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

The effect of flurbiprofen and naproxen sodium on intra-uterine pressure and menstrual pain in patients with primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751

7 January 2021

Pain relief in dysmenorrhea can be achieved more rapidly with ketoprofen than with naproxen

2

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Efficacy of indomethacin suppository in primary dysmenorrhoea

26 March 2024

4

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Comparison of fenoprofen calcium, ibuprofen and placebo in primary dysmenorrhea

26 March 2024

6

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

An attempt at real prophylaxis of primary dysmenorrhea: comparison between meclofenamate sodium and naproxen sodium

26 March 2024

8

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Mefenamic acid therapy in dysmenorrhea

26 March 2024

9

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Feldene in the symptomatic treatment of primary dysmenorrhoea

26 March 2024

11

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Effects of naproxen sodium on menstrual prostaglandins and primary dysmenorrhea

26 March 2024

12

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Efficacy of ketoprofen in treating primary dysmenorrhea

26 March 2024

25

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Primary Dysmenorrhea Treated With Indomethacin

26 March 2024

48

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Efficacy of fenoprofen in the treatment of primary dysmenorrhea

26 March 2024

51

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Treatment of dysmenorrhea with Pyrasanone

26 March 2024

70

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Ibuprofen therapy for dysmenorrhea

26 March 2024

82

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Revue francaise de gynecologie et d'obstetrique

26 March 2024

85

66

525

Boullaye

1971

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Lysine clonixinate in the treatment of primary dysmenorrhea

26 March 2024

87

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Treatment of primary dysmenorrhea and dysmenorrhea because of IUP with PG-synthetase inhibitors

26 March 2024

89

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Factors influencing adolescents' responses to regimens of naproxen for dysmenorrhea

26 March 2024

90

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Report of a double-blind crossover study to compare flurbiprofen with paracetamol in the treatment of primary dysmenorrhoea

26 March 2024

93

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

A clinical trial of indomethacin and ibuprofen in dysmenorrhea

26 March 2024

98

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

The treatment of premenstrual tension with mefenamic acid: analysis of prostaglandin concentrations

26 March 2024

109

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Naproxen sodium in dysmenorrhea secondary to endometriosis

26 March 2024

120

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Therapy of dysmenorrhea with prostaglandin synthetase inhibitors: experiences with fluproquazone

26 March 2024

127

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

A study of naproxen sodium and mefenamic acid in primary dysmenorrhoea

26 March 2024

130

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Dysmenorrhea: treatment with an antiprostaglandin

26 March 2024

132

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

A comparison of flurbiprofen and paracetamol in the treatment of primary dysmenorrhoea

26 March 2024

135

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Pirprofen, naproxen and placebo in the treatment of primary dysmenorrhoea

26 March 2024

137

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

Treatment of primary dysmenorrhoea with benorylate

26 March 2024

155

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

The dynamics of nonsteroidal anti-inflammatory therapy for primary dysmenorrhea

26 March 2024

173

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

A general practice study of naproxen sodium and a dextropropoxyphene-paracetamol combination in primary dysmenorrhoea

26 March 2024

180

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

A prevalence study of dysmenorrhoea in female residents aged 15-54 years in Clementi Town, Singapore

26 March 2024

197

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

New concepts in dysmenorrhea

26 March 2024

200

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001751

26 March 2024

Identifiers

0 references